SEC filings · customer concentration

Who depends on Rivex Pharma

Rivex Pharma appears in 1 disclosed customer relationships between 2011 and 2014.

0major customers now
—of revenue from them
0listed suppliers depending on it
2011–2014years covered
Free

Get an email when Rivex Pharma's customer concentration changes

When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.

Suppliers that depend on Rivex Pharma

Listed companies whose annual report names Rivex Pharma as a customer worth 10% or more of their revenue. If Rivex Pharma cuts orders or switches supplier, these are the companies that feel it.

Formerly disclosed

SupplierIts revenue from this companyChange vs prior yearHistoryLatest filing
Anika TherapeuticsANIK3%last FY 2013FY 2011: 1%FY 2012: 2%FY 2013: 3%3 yearsFY 2013 · filed 13 Mar 2014

About this data

US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.

All companies · Latest dependency shifts · Bulk data and API